Articles dans des revues avec comité de lecture (217)
  1. 48. Cogan, A., Barlow, P., Benali, N., Murillo, D., Manigart, Y., Belhomme, J., & Rozenberg, S. (2012). An audit about labour induction, using prostaglandin, in women with a scarred uterus. Archives of gynecology and obstetrics, 286(6), 1399-1406. doi:10.1007/s00404-012-2481-5
  2. 49. Plusquin, C., Fastrez, M., Vandromme, J., & Rozenberg, S. (2012). Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition. Maturitas, 73(2), 164-166. doi:10.1016/j.maturitas.2012.06.014
  3. 50. Palacios, S., Christiansen, C., Sánchez Borrego, R., Gambacciani, M., Hadji, P., Karsdal, M., Lambrinoudaki, I., Lello, S., O'Beirne, B., Romao, F., Rozenberg, S., Stevenson, J. C., & Ben-Rafael, Z. (2012). Recommendations on the management of fragility fracture risk in women younger than 70 years. Gynecological endocrinology, 28(10), 770-786. doi:10.3109/09513590.2012.679062
  4. 51. Antoine, C., Ameye, L., Paesmans, M., & Rozenberg, S. (2012). Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium. Maturitas, 72(4), 317-323. doi:10.1016/j.maturitas.2012.04.013
  5. 52. Fastrez, M., Naik, H. N., Corfers, A., & Rozenberg, S. (2012). Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Annals of medicine, 44(4), 404. doi:10.3109/07853890.2012.671539
  6. 53. Palacios, S., Brincat, M., Erel, C. T., Gambacciani, M., Lambrinoudaki, I., Moen, M. H., Schenck-Gustafsson, K., Tremollieres, F., Vujovic, S., Rees, M., & Rozenberg, S. (2012). EMAS clinical guide: selective estrogen receptor modulators for postmenopausal osteoporosis. Maturitas, 71(2), 194-198. doi:10.1016/j.maturitas.2011.11.010
  7. 54. Body, J.-J., Bergmann, P., Boonen, S., Devogelaer, J.-P., Gielen, E., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Reginster, J.-Y. (2012). Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporosis international, 23 Suppl 1, S1-23. doi:10.1007/s00198-011-1891-8
  8. 55. Pérez-López, F. R., Brincat, M., Erel, C. T., Tremollieres, F., Gambacciani, M., Lambrinoudaki, I., Moen, M. H., Schenck-Gustafsson, K., Vujovic, S., Rozenberg, S., & Rees, M. (2012). EMAS position statement: Vitamin D and postmenopausal health. Maturitas, 71(1), 83-88. doi:10.1016/j.maturitas.2011.11.002
  9. 56. Plusquin, C., Fastrez, M., Vandromme, J., & Rozenberg, S. (2011). Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey. Maturitas, 70(4), 391-394. doi:10.1016/j.maturitas.2011.09.007
  10. 57. Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Bruyere, O., Devogelaer, J.-P., Goemaere, S., Hollevoet, N., Kaufman, J.-M., Milisen, K., Rozenberg, S., & Reginster, J.-Y. (2011). Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club. Osteoporosis international, 22(11), 2769-2788. doi:10.1007/s00198-011-1545-x
  11. 58. Rozenberg, S., Vandromme, J., & Antoine, C. (2011). Réactualisation du traitement hormonal a la ménopause en 2011. Revue médicale de Bruxelles, 32(4), 239-242.
  12. 59. Antoine, C., Ameye, L., Moreau, M., Paesmans, M., & Rozenberg, S. (2011). Evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium. Climacteric, 14(4), 464-471. doi:10.3109/13697137.2011.561385
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Suivant >>